Home › Funds › BVF INC/IL › GPCR

BVF INC/IL position in GPCR

STRUCTURE THERAPEUTICS INC · Health Care

BVF INC/IL reported holding 3,366,823 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$180.7M, representing 4.62% of its reported portfolio and ranking #6 among its reported holdings. BVF INC/IL has disclosed GPCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.37M sh
Reported value held$180.70M
Portfolio Weight4.62%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's GPCR position evolved

BVF INC/IL first disclosed a stake in GPCR in Q3 2023 at 1,750,000 shares (US$88.2M). The position peaked in Q4 2025 at 3,479,022 shares, worth US$242.0M. Across 12 filings, BVF INC/IL increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 3,366,823 shares valued at US$180.7M — a reduction of -92,535 shares quarter over quarter.. Notable position changes include a 54% trim in Q4 2023 (shares rose 5% over the following quarter), a 206% increase in Q2 2024 (shares rose 12% over the following quarter), a 81% increase in Q3 2025 (shares rose 148% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.75M $88.23M New
Q4 2023 812.99K $33.14M Reduce
Q1 2024 812.99K $34.84M Hold
Q2 2024 2.49M $97.69M Add
Q3 2024 2.24M $98.27M Reduce
Q4 2024 1.77M $48.04M Reduce
Q1 2025 1.77M $30.66M Hold
Q2 2025 1.77M $36.74M Hold
Q3 2025 3.20M $89.71M Add
Q4 2025 3.48M $241.97M Add
Q1 2026 3.46M $166.74M Reduce
Q2 2026 3.37M $180.70M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GPCR and 13F data

GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), ORBIMED ADVISORS LLC (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GPCR

All GPCR fund holders →

FAQ

How long has BVF INC/IL held GPCR?

BVF INC/IL has disclosed GPCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in GPCR?

As of Q2 2026, BVF INC/IL holds 3.37M shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $180.70M, representing 4.62% of its reported portfolio and ranking #6.

Has BVF INC/IL been buying or selling GPCR?

In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in GPCR. The position peaked in Q4 2025 at 3.48M shares.

Which other funds hold GPCR?

Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, ORBIMED ADVISORS LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.